Inogen Inc — Form 8-K
Filed August 6, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 42/100
What the filing says
Inogen reported Q2 2026 revenue of $95.1M (up 3.0% YoY), with international sales up 14.8% to $41.3M offsetting U.S. sales decline of 2.3% to $42.3M. The company raised full-year 2026 adjusted EBITDA guidance to ~$4.0M (up 48.1% from 2025's $2.7M) and full-year revenue guidance to $355–361M (~3% growth). Q2 adjusted EBITDA was $2.4M (up 15.2% YoY); GAAP net loss improved to $3.9M from $4.2M. Cash position: $106.8M with no debt; company repurchased 1.14M shares for $7.5M in H1 2026.
Why this rating
Revenue guidance unchanged at ~3% growth; EBITDA margin improvement is real but company remains unprofitable on GAAP basis. Moderate progress relative to $190M market cap.
See more from August 6, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.